semaglutide patent india expiry in opens up huge opportunity for generic drugmakers: Report @zydusuniverse Read more link in bio. #Semaglutide #DiabetesCare #ObesityTreatment #PharmaNews #NovoNordisk #DrugPatent Last week's expiry of the

In the landscape of pharmaceuticals, Semaglutide , Ozempic , Wegovy, and Mounjaro are noteworthy contenders, each having a significant impact on the management of conditions such as obesity and type 2 diabetes

It allows for easy administration and is ideal for localized treatment

Gao L, Lee BW, Chawla M, Kim J, Huo L, Du L, et al

Copyright 2025 | NOMOS Srl Tecnologie del Software | C.F

Are There Any Situations Where Caution Is Needed

In the meantime, Eli Lilly should remain the leader in weight loss thanks to Zepbound, and other highly promising pipeline candidates, such as retatrutide, whose recent phase 3 results have been compared to what we typically see in bariatric surgeries